基本信息
views: 274
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
His translational research focus is on identifying biomarkers of response and resistance to targeted therapies and immunotherapies in lung cancer. He is the principal investigator of several clinical trials for patients with thoracic malignancies and collaborates closely with laboratory-based investigators. His research has been published in journals such as the New England Journal of Medicine, the Journal of Clinical Oncology, Cancer Immunology Research, and the Journal of Thoracic Oncology. He is a recipient of the 2015 Young Investigator Award from the American Society of Clinical Oncology (ASCO), the 2015 Young Investigator Award from the International Association for the Society of Lung Cancer (IASLC), the 2017 Career Development Award from Conquer Cancer Foundation of ASCO, and the 2018 ALK Positive/LUNGevity Transformational Research Award.
Research Interests
Papers共 437 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ONCOLOGISTno. 1 (2024): e166-e166
The New England journal of medicineno. 19 (2024): 1756-1769
A. Di Federico, S.L. Alden, J.W. Smithy,B. Ricciuti,J.V. Alessi, X. Wang,F. Pecci,G. Lamberti,M.M. Gandhi,V.R. Vaz,L.F. Spurr,L.M. Sholl,
Annals of Oncology (2024)
Cancer Discovery (2024)
Cancer Researchno. 6_Supplement (2024): 5064-5064
Nature Medicineno. 3 (2024): 907-907
HGG advancesno. 3 (2024): 100320-100320
The oncologistno. 5 (2024): 422-430
Cancer Researchno. 6_Supplement (2024): 2151-2151
Load More
Author Statistics
#Papers: 463
#Citation: 20786
H-Index: 66
G-Index: 142
Sociability: 8
Diversity: 0
Activity: 9
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn